Study to Assess Safety and Clinical Activity of Local MBN-101 in Treatment of Infected Bone Sites

NCT02436876 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

29

Enrollment

INDUSTRY

Sponsor class

Conditions

Bacterial Infection

Interventions

DRUG: MBN-101
OTHER: Placebo

Sponsor

Microbion Corporation

Collaborators

[object Object]
[object Object]
[object Object]
[object Object]